A new study suggests that e-cigarettes might help people cut down on their risk of developing some chronic conditions, including heart disease and stroke.
The study is the first to compare e-cigarette use with a control group of people who didn’t smoke cigarettes, which was used to gauge the effectiveness of the devices.
“E-cigarettes are not as effective as traditional tobacco products in reducing the risk of some chronic diseases,” the study’s authors wrote in a press release.
“But, e-cigs have been shown to be much more effective than conventional tobacco products for reducing the use of traditional cigarettes.”
The study used data from the National Cancer Institute, which tracks cancer deaths in the United States.
“We found that the e-cig users were more likely to be smokers who were also current smokers,” the researchers wrote.
“And they were also more likely than the controls to have developed a chronic condition such as cancer.”
While the authors were careful to note that this is just a preliminary study, they did conclude that “e-cigarettes may offer a promising tool to reduce smoking and reduce cancer risks in the future.”
“Evolving evidence” The study was based on data from a large group of Americans who were followed up between 2014 and 2018.
The researchers compared the people who smoked traditional cigarettes to people who used e-vaporizers.
They looked at how much e-juice people used and how often they smoked cigarettes.
While the results showed that people who had e-liquid consumption on a regular basis were significantly less likely to develop cardiovascular disease and to have cancer, the ejuice consumption rate for e-colas also varied.
“In other words, people who consumed e-milk had lower risk of cancer, but they had the same risk of cardiovascular disease,” said Dr. Jennifer Buhler, a cardiologist at Brigham and Women’s Hospital in Boston.
“If we can figure out what the mechanisms are for these different effects, we may be able to identify better ways to protect people from some of the most serious diseases.”
In the longer term, this could be important for people who want to quit smoking, but want to avoid developing certain diseases, Buhlers co-author Dr. David Felson told Ars.
“For instance, you can look at reducing smoking by having a better diet and a better lifestyle, and it’s not just about reducing nicotine, but also increasing physical activity and getting enough sleep,” he said.
“It’s just that we need to really be studying those things, because they could be the difference between quitting smoking and developing chronic disease.”
The researchers found that people in the eVaporizers group were more than twice as likely to have a heart attack and stroke than the control group.
While e-Vaporizer users were much more likely, and smokers were much less likely, to develop heart disease, the overall health benefits of vaping were much higher.
“The effect of vaping is quite profound, and is quite large,” Buhner told Ars in an interview.
“You know, the number one reason why I was vaping was because I was going to try to quit,” she said.
Buhrer told Ars that she is not surprised that people are using e-tobacco to reduce their risk.
“I think it’s an inevitable consequence of our environment,” she told us.
People are trying to help people quit, but it’s going to take a lot more work to get there.”